Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: Madrigal org | History Defined

Rezdiffra Whistleblower Lawsuit Claims Madrigal Forced Out Its Former Clinical Chief Over Liver Injury Data Concerns

Michael Charlton alleges Madrigal Pharmaceuticals retaliated after he raised concerns about liver-injury data linked to Rezdiffra. The company denies the claims, while the FDA's approval and warnings remain unchanged.

Medical Daily · Nov 6

CoreWeave and Madrigal's Insider Trades Flash Bullish Signals

Insider trades at NVIDIA-backed CoreWeave and Madrigal Pharmaceuticals are bullish indicators, but for very different reasons.

MarketBeat · Sep 10, 2025

US Approves First Drug For Severe Form Of Fatty Liver Disease

The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.

International Business Times · Mar 15, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

Analysts Believe Madrigal's Resmetirom Shows Impressive Overall Profile In Liver Fibrosis

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) presented multiple resmetirom abstracts at the European Association for the Study of the Liver's International Liver Congress. The data included new details on changes in FibroScan controlled attenuation parameter and liver stiffness measurement along with magnetic resonance elastography, which serves as critical non-invasive measures of liver stiffness and fibrosis. …

Benzinga · Jun 27, 2022

Madrigal Announces Debt Funding Of $250M To Back Potential US Resmetirom Launch

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) secured a $250 million term loan facility from Hercules Capital Inc (NYSE:HTGC), providing additional funding to support the expanded clinical program and ramp-up for a potential US launch of resmetirom. The company drew $50 million from the facility at closing and can draw a further $200 million under the agreement. Related…

Benzinga · May 9, 2022

Coverage From

Organisations

Food and Drug Administration

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United States

436,708 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.